Karyopharm Announces Positive Top-Line Data from Phase 2b STORM Study Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil tops $100, yields hit 2023 high; Apple down before Ternus' first launch event as CEO
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Karyopharm Therapeutics (KPTI) PT Raised to $21 at Wedbush
May 1, 2018 9:59 AM EDTWedbush raised its price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $21.00 (from $19.00) while maintaining a Outperform rating.
Analyst David Nierengarten commented, "Topline results from STORM met our expectations and should be sufficient to support accelerated approval (AA) for selinexor plus dex in... More
Karyopharm Therapeutics (KPTI) PT Raised to $24 at RBC Capital; 'We Would Be Buyers'
May 1, 2018 7:58 AM EDTRBC Capital raised its price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $24.00 (from $22.00) while maintaining a Outperform rating.
Analyst Brian Abrahams commented, "Expanded ph.II STORM data for selinexor in MM looks to have met the ORR/DOR bar for confirming its likely... More
Karyopharm Therapeutics (KPTI) to Resume Trading at 4:35 pm ET
April 30, 2018 4:16 PM EDTKaryopharm Therapeutics (NASDAQ: KPTI) to Resume Trading at 4:35 pm ET
... More